Rett Syndrome Rtt clinical trials

Explore recruiting rett syndrome rtt clinical trials.

Recruiting rett syndrome rtt studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rett Syndrome Rtt trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Repurposing mirtazapine in Rett syndrome: a multicentric open label Phase II study (MirtaRett Study).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 randomized, double-blind, placebo-controlled, parallel group, multicenter study with open-label extension to evaluate the efficacy and safety of fenfluramine hydrochloride in study participants with Rett syndrome

Spain, Poland, France, Hungary, Belgium, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rett Syndrome Rtt trials by city

Rett Syndrome Rtt in Toronto Rett Syndrome Rtt in Vancouver Rett Syndrome Rtt in Montreal Rett Syndrome Rtt in Calgary Rett Syndrome Rtt in Edmonton Rett Syndrome Rtt in Ottawa Rett Syndrome Rtt in Winnipeg Rett Syndrome Rtt in Quebec City Rett Syndrome Rtt in Hamilton Rett Syndrome Rtt in Kitchener Rett Syndrome Rtt in London Rett Syndrome Rtt in Halifax Rett Syndrome Rtt in New York Rett Syndrome Rtt in Los Angeles Rett Syndrome Rtt in Chicago Rett Syndrome Rtt in Houston

Rett Syndrome Rtt clinical trials

Recruiting rett syndrome rtt studies right now

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome

Repurposing Mirtazapine in Rett Syndrome

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome

Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome

Also recruiting in Europe

Repurposing mirtazapine in Rett syndrome: a multicentric open label Phase II study (MirtaRett Study).

A Phase 3 randomized, double-blind, placebo-controlled, parallel group, multicenter study with open-label extension to evaluate the efficacy and safety of fenfluramine hydrochloride in study participants with Rett syndrome

Rett Syndrome Rtt trials by city

Other conditions